Delyth Morgan

Baroness Delyth Morgan, CEO of Breast Cancer Now, tells us about some of the things she's been part of in her 25 years with the charity, as well as how we are focusing more on people with secondary breast cancer.

13 October 2021 Breast Cancer Now

A group of women meeting at parliament in order to speak with MPs about secondary breast cancer

We’re committed to improving treatment, care and services for people living with secondary breast cancer, which is why it’s a central part of our new strategy. 

9 October 2021 Breast Cancer Now

Secondary report hand-in

Today, we are excited to announce that we have finally secured a long-overdue secondary breast cancer audit in England, delivering on one of the key calls from our Unsurvivors campaign.

7 October 2021 Breast Cancer Now

Jen, a white woman with mid-length blonde hair and round glasses, smiles in a field of daffodils while wearing a yellow hoodie

In 2017, Jen received a de novo diagnosis of secondary breast cancer after experiencing some unusual symptoms. She tells us about the misconceptions she had about cancer, and how she's working with Breast Cancer Now to campaign for change.

29 July 2021 Breast Cancer Now

A female health care provider speaks with two older women

The experiences of people living with secondary breast cancer are unique, which is why our secondary breast cancer campaign has been calling for these experiences to be acknowledged and understood. 

14 July 2021 Breast Cancer Now

dozens of pills of all shapes and sizes spread out on a counter

A new targeted drug for treating breast cancer that has spread has been approved by the National Institute for Health and Care Excellence (NICE) for use on the Cancer Drugs Fund.

20 April 2021 Breast Cancer Now

Our 2019 report, which looked at the experiences of over 2,000 people living with secondary breast cancer, found that many were experiencing avoidable delays in diagnosis.

9 April 2021 Breast Cancer Now

close up of gloved hands isolating a sample

Our Policy team have an update on the ongoing NICE methods and process review, and how we’re helping to ensure the system works for breast cancer drugs. 

25 March 2021 Breast Cancer Now

close up of dozens of different pills and medications

Drugs are a cornerstone of treatment for breast cancer. We know that you may have questions about drug treatment following the transition period ending on 31 December 2020. We take a look at what this means for medicines supply, medicines licensing, and clinical trials.

23 March 2021 Breast Cancer Now